Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.23% is 32% below its 2-year average of 3.26%, near the low end of its 2-year range (2.03%–7.53%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.55% above its 12-month average of 2.21%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.23%.
DEBT TO ASSETS RATIO
2.23%
DEBT TO ASSETS RATIO AVG TTM
2.21%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.55%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+1924.71%
vs the sector median at left
Beta Bionics, Inc.
Market Cap
$852.55M
Debt to Assets Ratio
2.23%
TTM Avg
2.21%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.60M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$819.44M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$903.13M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $852.55M | 2.23% | 2.21% | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $844.28M | 0.06% | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | 0.05% | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | 0.44% | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | 0.02% | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $812.20M | 0.01% | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | 0.00% | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $915.95M | 0.39% | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | 0.06% | N/A | N/A | N/A |
Debt/Assets
2.2%
Debt/Equity
0.03
Current Ratio
8.88
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.23% |
| 2026-03-31 | 2.27% |
| 2025-12-31 | 2.22% |
| 2025-09-30 | 2.33% |
| 2025-06-30 | 2.03% |
| 2025-03-31 | 2.06% |
| 2024-12-31 | 4.85% |
| 2024-09-30 | 7.53% |
| 2023-12-31 | 3.84% |
